No Data
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
French drugmaker Sanofi is poised to commit between 1.3 billion euros and 1.5 billion euros ($1.4 billion – $1.6 billion) to enhancing its insulin production site in Frankfurt, Germany.The site in Fra
Bird Flu Vaccine Faces Hurdles Without Better Data, Critics Say
Sanofi plans to invest up to $1.6 billion to upgrade its factory in Germany.
According to German Business Daily, French pharmaceutical company Sanofi is about to decide to invest 1.3 billion to 1.5 billion euros (about 1.4 billion to 1.6 billion US dollars) in a large production base in Frankfurt, Germany, to produce insulin Lantus. The report cited German government sources as saying that Sanofi changed its route after initially considering moving Lantus production to France, and the company is now close to committing to upgrading its German factory in the Hürth district of Frankfurt.
Sector Update: Health Care Stocks Mixed Premarket Monday
Health care stocks were mixed premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was 0.3% higher and the iShares Biotechnology ETF (IBB) was down 0.2% recently. SpringWorks Therapeutics
Wall Street Kicks Off H2 as US Equity Futures Waver Pre-Bell
US equity futures were little changed before Monday's opening bell as investors geared up for the second half of the year. Dow Jones Industrial Average futures gained 0.1%, S&P 500 futures increased 0
Sanofi Reports Findings From Phase II Relapsing MS Treatment Trial